Comparative Cardiovascular and Renal Effectiveness and Safety of Empagliflozin in Patients with Type 2 Diabetes, with and without Baseline Kidney Disease in the United States

Project: Research project

Project Details

StatusActive
Effective start/end date12/13/213/31/22

Funding

  • Duke University (Agmt 12/13/2021)
  • Boehringer Ingelheim International GmbH (Agmt 12/13/2021)